Advertisement

  • News
  • Columns
  • Interviews
  • BW Communities
  • Events
  • BW TV
  • Subscribe to Print

Latest Articles in sanofi

Sanofi, GSK Launch Trial For COVID-19 Protein-based Vaccine

If the results are conclusive, Sanofi and GSK hope to get the vaccine approved in the first half of next year.

Read More

Sanofi, GSK Launch Trial For COVID-19 Protein-Based Vaccine

Sanofi and GSK said on Thursday that they had started the "Phase 1/2" trial for their adjuvanted COVID-19 vaccine, which they hope to make available across the world.

Read More

Sanofi Snags Another US Biotech Asset With $3.7 Billion Deal For Principia Biopharma

Sanofi shares edged up 0.6% in early session trading, bucking a slight fall in France's CAC-40 index, as analysts were positive on the deal.

Read More

EU In Talks To Secure Sanofi Deal For Coronavirus Vaccine

The European Commission wants to strike deals with up to six drugmakers for their vaccines for their 450 million citizens against the coronavirus that has killed 674,000 people worldwide.

Read More

Sanofi Eyes Approval Of COVID-19 Vaccine By First Half Of 2021

There are currently no vaccines to prevent the coronavirus that has infected more than 9 million people and killed over 469,000 globally, and only a couple of medicines that have demonstrated benefit in hospitalized COVID-19 patients in clinical trials.

Read More

Sanofi Eyes Approval Of COVID-19 Vaccine By First Half Of 2021

Sanofi, which is hosting a virtual research and development event, and GSK had said in April the vaccine, if successful, would be available in the second half of 2021.

Read More

MNC Pharma: Opportunity In The Middle Of A Crisis!

MNC stocks like prized diamonds collected over a period of time and not bought one fell swoop. So be patient but keep a close eye on these two gems!!

Read More

Sanofi To Run Consultations Over Restart Of Hydroxychloroquine Trials

"We will review available information and run consultations in the coming days to reassess our position," a spokesman with Sanofi said.

Read More

Sanofi Stops Enrolling COVID-19 Patients In Hydroxychloroquine Trials Amid Safety Concerns

The moves come after the World Health Organization paused its large trial of hydroxychloroquine after the British journal The Lancet reported patients getting the drug had increased death rates and irregular heartbeats.

Read More

Drugmaker Sanofi To Raise Over $11 Billion Via Sale Of Regeneron Shares

Sanofi is selling the Regeneron shares at $515.00 per share - a discount of around 5.5% to Regeneron's closing price of $545.21 on May 26, and raising gross proceeds of $11.1 billion.

Read More

Sanofi Says COVID-19 Vaccine Will Be Available Worldwide Simultaneously

The group's chief executive Paul Hudson said on Thursday it was vital that any coronavirus vaccine reach all parts of the world

Read More

US Priority On Sanofi Virus Vaccine Would Be Unacceptable, Says France

The companies have received financial support from the Biomedical Advanced Research and Development Authority (BARDA) of the U.S. Health Department.

Read More

Sanofi Confirms Targets, Strong Demand For Pain Killers Lifts First Quarter

Net income was up 16.1% at constant exchange rates in the first quarter to 2.04 billion euros

Read More

To Donate 100 Million Doses Of Hydroxychloroquine Across 50 Countries

Sanofi called for coordination among the entire hydroxychloroquine chain worldwide to ensure the continued supply of the medicine if proven to be a well-tolerated and effective treatment in COVID-19 patients.

Read More

Sanofi, Regeneron Expand Testing Of Potential Coronavirus Treatment

Italy and Spain have been two of the worst-hit countries in Europe, recording the highest and the second highest death toll from coronavirus of any country in the world, respectively.

Read More